Erratum for the Research Article: “Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors” by D. C. Kirouac, J. Y. Du, J. Lahdenranta, R. Overland, D. Yarar, V. Paragas, E. Pace, C. F. McDonagh, U. B. Nielsen, and M. D. Onsum

Sci. Signal.  30 Sep 2014:
Vol. 7, Issue 345, pp. er5
DOI: 10.1126/scisignal.2005942

Log in to view full text

Via your Institution

Log in through your institution

Log in through your institution